Market Place
Sourcing Support
Prevail Partners And InfoWorks Invest In Kairos Pharma Alliance
25 Sep 2024 //
ACCESSWIRE
Lilly`s Prevail walks away from Precision gene editing collab
17 Apr 2024 //
FIERCE BIOTECH
Lilly taps Sangamo to explore AAV capsids for neurological targets
18 Jul 2023 //
PRESS RELEASE
Lilly`s Prevail drops deal value for Precision gene therapy pact
07 Jul 2023 //
FIERCE BIOTECH
Scribe`s CRISPR tech Prevails with new $1.5B Lilly biobucks deal
17 May 2023 //
FIERCE BIOTECH
Prevail, Capsida partner to develop gene therapies for nervous system diseases
05 Jan 2023 //
BIOPHARMADIVE
Lacerta & Prevail, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders
23 Aug 2022 //
BUSINESSWIRE
Lilly to create $700mn Institute for Genetic Medicine
23 Feb 2022 //
EUROPEANPHARMACEUTICALREVIEW
Asa Abeliovich and OrbiMed are teaming on yet another biotech
14 Feb 2022 //
ENDPTS
Lilly Completes Acquisition of Prevail Therapeutics
22 Jan 2021 //
PRNEWSWIRE
Lilly Acquires Prevail and Gene Therapy for Neuronopathic Gaucher
21 Dec 2020 //
GAUCHERDISEASENEWS
Eli Lilly to buy gene therapy developer Prevail in $1.04 billion deal
16 Dec 2020 //
CNBC
J&J Prevails In Tenn. Woman`s Pelvic Mesh Suit At 6th Circ.
15 Dec 2020 //
LAW360
Viatris to shut or sell two plants in India as part of global restructuring
15 Dec 2020 //
MONEYCONTROL
Prevail Announces First Patient Dosed in Ph 1/2 PROCLAIM Trial PR006
11 Dec 2020 //
GLOBENEWSWIRE
Prevail Receives European Commission Orphan Designation for PR006
30 Nov 2020 //
GLOBENEWSWIRE
Prevail and Alector both claim victory in arbitration over scientist-CEO
03 Nov 2020 //
ENDPTS
Prevail Receives U.S. FDA Fast Track Designation for PR001
27 Oct 2020 //
GLOBENEWSWIRE
Prevail to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
18 Sep 2020 //
BIOSPACE
Prevail to Highlight Multiple Gene Therapy Programs Neurodegenerative Diseases
22 Jul 2020 //
GLOBENEWSWIRE
Prevail Therapeutics to Highlight Multiple CNS-Focused Gene Therapy at 2020
29 Apr 2020 //
GLOBENEWSWIRE
Prevail Therapeutics to Present at AAT-AD/PD Focus Meeting 2020
31 Mar 2020 //
GLOBENEWSWIRE
Prevail Therapeutics Provides Clinical Advancement Update on PR001
03 Mar 2020 //
GLOBENEWSWIRE
Prevail Announces Investigational New Drug Application Active for PR006
02 Mar 2020 //
GLOBENEWSWIRE
Prevail’ PR001 Receives Orphan Drug Designation and Rare Pediatric Disease
12 Feb 2020 //
GLOBENEWSWIRE
Prevail`s gene therapy scores orphan, rare pediatric disease privileges
12 Feb 2020 //
ENDPTS
Paul Sidney Joins Altasciences as Senior Director
09 Jan 2020 //
GLOBE NEWSWIRE
Prevail Therapeutics Announces FDA Orphan Drug Designation Granted to PR006
16 Dec 2019 //
GLOBE NEWSWIRE
Prevail and Lonza Deepen Partnership with New Collaboration
09 Oct 2019 //
BIOSPACE
Alector, Prevail trade blows over founder`s work
17 Aug 2019 //
FIERCE BIOTECH
Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR001
08 Jul 2019 //
GLOBE NEWSWIRE
Gene therapy biotech Prevail Therapeutics files for a $100 million IPO
24 May 2019 //
NASDAQ
